These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1350733)
61. [Interaction of rilmenidine with renal imidazoline-guanidine sites]. Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516 [TBL] [Abstract][Full Text] [Related]
62. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Sannajust F; Cerutti C; Koenig-Bérard E; Sassard J Br J Pharmacol; 1992 Mar; 105(3):542-8. PubMed ID: 1352719 [TBL] [Abstract][Full Text] [Related]
63. Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension. Nowak Ł; Adamczak M; Wiecek A Am J Hypertens; 2005 Nov; 18(11):1470-5. PubMed ID: 16280284 [TBL] [Abstract][Full Text] [Related]
64. Dose and concentration-effect relations for rilmenidine. Dollery CT; Davies DS; Duchier J; Pannier B; Safar ME Am J Cardiol; 1988 Feb; 61(7):60D-66D. PubMed ID: 2894161 [TBL] [Abstract][Full Text] [Related]
65. [Imidazoline receptors and use of drug blocking receptors I1]. Lada W Pol Merkur Lekarski; 1996 Aug; 1(2):124-5. PubMed ID: 9156911 [TBL] [Abstract][Full Text] [Related]
66. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. Chan CK; Sannajust F; Head GA J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304 [TBL] [Abstract][Full Text] [Related]
67. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Chen JM; Heran BS; Perez MI; Wright JM Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622 [TBL] [Abstract][Full Text] [Related]
68. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
69. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups]. Scemama M; Février B; Beucler I; Dairou F Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699 [TBL] [Abstract][Full Text] [Related]
70. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine. Szabo B; Urban R Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413 [TBL] [Abstract][Full Text] [Related]
71. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension. Wong GW; Laugerotte A; Wright JM Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578 [TBL] [Abstract][Full Text] [Related]
72. Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta-analysis. Érszegi A; Viola R; Bahar MA; Tóth B; Fejes I; Vágvölgyi A; Csupor D Pharmacol Res Perspect; 2024 Jun; 12(3):e1215. PubMed ID: 38807350 [TBL] [Abstract][Full Text] [Related]
73. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension. Chen JM; Heran BS; Wright JM Cochrane Database Syst Rev; 2009 Oct; (4):CD007187. PubMed ID: 19821398 [TBL] [Abstract][Full Text] [Related]
74. Treating essential hypertension. The first choice is usually a thiazide diuretic. Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125 [TBL] [Abstract][Full Text] [Related]
75. Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects. de Visser SJ; van Gerven JM; Schoemaker RC; Cohen AF Br J Clin Pharmacol; 2001 May; 51(5):423-8. PubMed ID: 11421999 [TBL] [Abstract][Full Text] [Related]
76. Treatment of systemic hypertension in insulin-treated diabetes mellitus with rilmenidine. Mpoy M; Vandeleene B; Ketelslegers JM; Lambert AE Am J Cardiol; 1988 Feb; 61(7):91D-94D. PubMed ID: 2894167 [TBL] [Abstract][Full Text] [Related]
77. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males. Weerasuriya K; Shaw E; Turner P Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856 [TBL] [Abstract][Full Text] [Related]
78. Treatment of hypertension in diabetic patients. Lambert AE; Mpoy M; Vandeleene B; Ketelslegers JM Am J Med; 1989 Sep; 87(3C):30S-33S. PubMed ID: 2782324 [TBL] [Abstract][Full Text] [Related]
79. Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients. Aparicio M; Dratwa M; el Esper N; Fillastre JP; Levaltier B; Lins R; Meyrier A; Mignon F; Ryckelynck JP; Sennesael J Am J Cardiol; 1994 Dec; 74(13):43A-50A. PubMed ID: 7998585 [TBL] [Abstract][Full Text] [Related]
80. Sites of actions of alpha 2 agonists in the brain and periphery. Louis WJ; Jarrott B; Conway EL Am J Cardiol; 1988 Feb; 61(7):15D-17D. PubMed ID: 2894151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]